Abstract Osteoporosis is a systemic disease characterized by bone degradation and decreased bone mass that promotes increased bone fragility and eventual fracture risk. Studies have investigated the use of sodium fluoride (NaF) for the treatment of osteoporosis. However, fluoride can alter glucose homeostasis. The aim of this study was to evaluate the effects of NaF intake (50 mg/L) from water on the following parameters of ovariectomized (OVX) rats: (1) tyrosine phosphorylation status of insulin receptor substrate (pp185 (IRS-1/IRS-2)) in white adipose tissue; (2) insulin sensitivity; (3) plasma concentrations of glucose, insulin, total cholesterol, triglyceride, TNF-α, IL-6, osteocalcin, calcium, and fluoride; (4) bone density and biomechanical properties in the tibia; and (5) tibia histomorphometric analysis. Fifty-two Wistar rats (2 months old) were ovariectomized and distributed into two groups: control group (OVX-C) and NaF group (OVX-F), which was subjected to treatment with NaF (50 mg/L) administered in drinking water for 42 days. The chronic treatment with NaF promoted (1) a decrease in pp185 (IRS-1/IRS-2) tyrosine phosphorylation status after insulin infusion in white adipose tissue and in insulin sensitivity; (2) an increase in the plasma concentration of insulin, fluoride, osteocalcin, calcium, triglyceride, VLDL-cholesterol, TNF-α, and IL-6; (3) a reduction in the trabecular width, bone area, stiffness, maximum strength, and tenacity; (4) no changes in body weight, food and water intake, plasma glucose, total cholesterol, HDL-cholesterol, LDL-cholesterol, bone mineral content, and bone mineral density. It was concluded that chronic treatment with NaF (50 mg/L) in OVX rats causes a decrease in insulin sensitivity, insulin signaling transduction, and biochemical, biomechanical, and histomorphometric bone parameters.
Introduction
Patients with type 1 diabetes mellitus show a lack of insulin and do not reach the peak of bone mass, leading to a decrease in bone mineral density and an increase in the risk of fractures. On the other hand, patients with type 2 diabetes mellitus show hyperinsulinemia that stimulates bone formation. This can be explained by the fact that insulin is an anabolic factor to the bones [1] .
Osteoporosis is defined as a systemic disease affecting the skeleton and is characterized by decreased bone mass and microarchitectural deterioration, with a consequent increase in bone fragility and risk of fracture [2] .
Several studies have investigated the use of fluoride for the treatment of osteoporosis [3, 4] . Fluoride can accumulate in calcified tissues such as teeth and bones, altering the quality of these tissues [5, 6] . Researchers have demonstrated that fluoride has osteogenic effects, such as increasing the number of osteoblasts in response to stimulation and proliferation of osteoblast precursors, as well as antiresorptive capacity [7] . Furthermore, studies have demonstrated that fluoride treatment increases bone density; however, it may decrease biomechanical properties. Therefore, the increase in bone mass induced by treatment with NaF does not necessarily correspond to increased bone strength [8] .
Besides influencing bone metabolism, fluoride can also alter glucose homeostasis [9, 10] . Studies with castrated male rats demonstrated that chronic treatment with NaF promoted insulin resistance and decreased insulin signaling [11] [12] [13] . In addition, chronic treatment with fluoride in castrated rats also increased the IRS-1 serine phosphorylation status in adipose tissue, resulting in the attenuation of insulin signal transduction [11, 13] .
There is no consensus about the effectiveness of NaF in promoting the formation of healthy bone [14] , and, depending on the dosage, fluoride can promote changes in glycemic homeostasis [11, 13, 15] and insulin sensitivity [16] . Therefore, the aim of this study was to examine the effect of chronic treatment with NaF (50 mg/L in drinking water) on the insulin sensitivity, insulin signal transduction, and biomechanical and histomorphometric parameters in the bone of ovariectomized (OVX) rats.
Materials and Methods

Animal Grouping and Treatments
All experimental procedures were approved by the Institutional Committee on Animal Research and Ethics (Protocol No. 00941-2013). Fifty-two 2-month-old female Wistar rats were kept under a 12/12-h light/dark cycle (lights on at 0700) and room temperature of 21 ± 2°C, with free access to a regular laboratory rat diet (Presence®; Evialis Industry of Brazil Ltd., Paulinia, Brazil) and water. Under anesthesia (80 mg/kg ketamine and 10 mg/kg xylazine), bilateral ovariectomies were performed in all the rats. These rats were distributed into two groups: the control group (OVX-C), which was subjected to a solution of NaCl (9.54 mg/kg body weight) containing the same amount of sodium as that received by the NaF group, and the NaF group (OVX-F; hereafter also referred to as BF-treated rats^), which was treated with NaF (50 mg/L) administered in drinking water. During 42 days, the volume of water consumed by each rat in a day in both groups was measured 3 days per week. At the end of this period, the animals from both the OVX-C and OVX-F groups were fasted from food for 14 h and the OVX-F group was deprived from the NaF solution for 4 h before the day of the experimental measurements to avoid an acute fluoride effect. Both groups of rats were then anesthetized with sodium thiopental (Thiopentax®; Cristália Pharmaceutical Chemicals Ltd., Itapira, Brazil; 3 %, 5 mg/100 g body weight, intraperitoneally). Ten control and ten F-treated rats were subjected to the intravenous insulin tolerance test (0.75 U insulin/kg body weight). The left tibiae of these same animals were also acquired to evaluate the effect of the treatment with NaF on the fluoride concentration in the bone, and the right tibiae were used for immunohistochemical analysis. Six control and six F-treated rats were used to quantify the pp185 (IRS-1/IRS-2) tyrosine phosphorylation status in the white adipose tissue after regular human insulin (1.5 U, intravenously) administration. Median laparotomy was performed in ten control and ten F-treated rats, and blood was collected from the inferior vena cava. The plasma samples from these animals were stored at −70°C until quantification of the plasma concentrations of glucose, insulin, total cholesterol (TC), triglyceride (TG), tumor necrosis alpha (TNF-α), interleukin-6 (IL-6), calcium, and fluoride. The left tibiae of these same animals were also acquired for biomechanical analysis, and the right tibiae were used for histomorphometric analysis.
Evaluation of Bone Mineral Density and Biomechanical Parameters
The total area (cm 2 ), bone mineral content (BMC; g), and bone mineral density (BMD; g/cm 2 ) were measured by whole left tibia dual X-ray absorptiometry (DXA; Lunar DPX Alpha; Lunar Corp., Madison, WI, USA). The biomechanical properties of the tibiae of rats were evaluated by 3-point bending, using a universal testing machine (DL 3000; EMIC®, SP, Brazil). Each tibia was loaded centrally in the diaphysis medium, with a support distance range of two thirds of the bone length, and a load cell of 2000 N was applied at a rate of 5 mm/ min until the bone fractured. The load and displacement of the cross bar of the machine were monitored and recorded using a software program (DL 3000; EMIC®, SP, Brazil). From these data, the load-displacement curves were obtained. The maximum load (Fmax) represents the highest load that the bone can support. In fact, it is a precise parameter for directly evaluating the resistance of the bone. The slope of the elastic region of the load-displacement curve is the extrinsic stiffness (×10 3 N/m) of the structure, and the area under the load-displacement curve (i.e., the area of the elastic strain region plus the area of the plastic strain region) is a measure of the amount of energy required to cause a bone fracture [17] .
Analysis Methods
The plasma samples were used for the determination of glycemia by the oxidase glucose method (enzymatic glucose; ANALISA Diagnóstica, Belo Horizonte, MG, Brazil) and insulinemia by the radioimmunoassay method (Coat-aCount, DPC; Diagnostic Products, Los Angeles, CA, USA). Insulin resistance was evaluated from the homeostasis model assessment of insulin resistance (HOMA-IR) index, calculated using the following formula: HOMA-IR = fasting glycemia (mmol/L) × fasting insulinemia (μUI/mL)/22.5 [18] .
Determination of TNF-α
Blood samples were collected from the inferior vena cava to measure the plasma TNF-α concentration. After centrifugation, the supernatant was collected and maintained at −70°C until use. A 96-well plate was coated with a monoclonal antibody to TNF-α. Samples and recombinant TNF-α were added to the wells, and, after 2 h, unbound proteins were washed away and an enzyme-linked polyclonal antibody was added to the wells; this antibody acted as a link between TNF-α and the dye, whereby a color change proportional to the amount of TNF-α was observed. This color change was quantified by comparing the optical densities of the samples with those of known dilutions, using a plate reader at 450 nm. The concentration of TNF-α was calculated from a standard curve, in units of picogram/milliliter.
Determination of IL-6
The concentration of plasma IL-6 was determined by ELISA, using a commercial kit specific for rats according to the manufacturers' instructions (BD Biosciences, San Diego, USA; and Biovedor, Heidelberg, Germany).
Determination of Osteocalcin
The concentration (pg/mL) of plasma osteocalcin was determined by ELISA, using a commercial kit specific for rats according to the manufacturer's instructions (USCN Life Science Inc., Houston, TX, USA).
Determination of Triglyceride, Total Cholesterol, High-Density Lipoprotein Cholesterol, Low-Density Lipoprotein Cholesterol, and Very Low-Density Lipoprotein Cholesterol Levels Blood samples were collected from the inferior vena cava to measure the plasma concentrations of TG, TC, and highdensity lipoprotein cholesterol (HDL-C). After centrifugation, the supernatant was collected and stored at −20°C until use. Plasma concentrations of TG, TC, and HDL-C were measured using an enzymatic colorimetric method (Labtest Diagnostica S.A., Lagoa Santa, Minas Gerais, Brazil), using a spectrophotometer at wavelengths of 505, 500, and 500 nm, respectively.
The levels of low-density lipoprotein cholesterol (LDL-C) and very low-density lipoprotein cholesterol (VLDL-C) were determined from the values obtained for TG, TC, and HDL-C, using the Friedewald equation [19] .
Determination of Fluoride Ion Concentration in Blood Plasma
For analysis of the fluoride ion level in plasma, pre-diffusion with heated hexamethyldisiloxane (HMDS)-H 2 SO 4 was done to remove CO 2 . The fluoride ion concentration in plasma was determined after 12 h of diffusion facilitated by the HMDS [20] , as modified by Whitford [21] , using a fluoride ionselective electrode (Model 9409; Orion Research, Cambridge, MA, USA) and a calomel reference microelectrode (#13-620-79; Accumet) coupled to a potentiometer (Model EA 940; Orion Research), as described by Buzalaf et al. [22] .
Determination of Fluoride Ion Concentration in Tibiae
Bone fluoride ion levels were measured by direct potentiometry, using an ion-selective electrode (Orion 94-09; Orion Research), after isothermal distillation [23] . Prior to the measurements, the bone tissue was incinerated for 6 h at 550°C.
Determination of Calcium Levels
Calcium measurements were performed by a spectrophotometric method, using a commercial kit according to the manufacturer's instructions (Labtest Diagnóstica S.A.).
Short Intravenous Insulin Tolerance Test
The intravenous insulin tolerance test (ITT) was carried out on ten animals of each group (OVX-C and OVX-F) as follows. The test was performed with the animals anesthetized as described in the section BAnimal Grouping and Treatments.Ĉ annulation of the right jugular vein was conducted, introducing the sylastic cannula in proximity to the atrium (superior vena cava). This cannula served as the venous access for injection of insulin, which was administered at a dose of 0.75 U/ kg body weight. Blood samples (50 μ/L) were collected from nicked tails at 0 (before hormone administration), 4, 8, 12 , and 16 min after insulin administration, and the glucose level was measured using a glycemia monitor (ACCU-CHEK Advantage; Roche Diagnostics, Indianapolis, IN, USA). The results were analyzed by comparison of the rate constant for glucose disappearance (K itt value) from 0 to 16 min of the test.
The K itt value was calculated using the equation 0.693/t 1/2 . The glucose t 1/2 value was calculated from the slope of the least-square analysis of the plasma glucose concentrations during the linear-decay phase [24] .
Evaluation of the Tyrosine Phosphorylation Status of the Insulin Receptor Substrate
Samples of white adipose tissue were collected from six animals of each group (OVX-C and OVX-F) before and after (120 s) the administration of 1.5 U of regular insulin. Tissue samples were prepared according to the method described by Carvalho et al. [5] and subjected to the western blot assay for quantification of the pp185 (IRS-1/IRS-2) tyrosine phosphorylation status, using the anti-phosphotyrosine antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA). Immunoreactive bands were detected by autoradiography, using a chemiluminescent substrate system (Santa Cruz Biotechnology) according to the instructions of the manufacturer. Quantitative analysis of the blots was performed by using an image analysis software (NIH Image v.b3b; National Institutes of Health, Bethesda, MD, USA) [24] .
Histomorphometric Analysis
For histomorphometric analysis, ten animals from each group were used. The right tibia was collected and fixed in 4 % formaldehyde for 24 h. Decalcification was performed in Plank-Rychlo's solution. Specimens were routinely processed, embedded in paraffin, and sectioned longitudinally. Semi-serial sections (5-μm thickness) of the right tibia were obtained and stained with hematoxylin and eosin. Three equidistant sections from the center of the bone were selected from each specimen and imaged using a digital camera coupled to a light microscope. The cancellous bone compartment of the tibial proximal metaphysis was analyzed. This analysis was performed in the center of the metaphysis with a ×200 magnification in an area of 840 μm × 560 μm located at 1 mm below the growth plate. Analysis was carried out using the ImageJ public domain image analysis system. The following bone histomorphometric parameters were measured: percentage of cancellous bone in the area analyzed; B.Ar, cancellous bone area (mm 2 ); Tb.N, trabecular number per mm 2 ; and Tb.Wi, trabecular width (μm). All nomenclature, symbols, and units for bone histomorphometry were expressed as recommended by the American Society for Bone and Mineral Research Histomorphometry Nomenclature Committee [25] .
Immunohistochemistry
The slides were separated and destained for immunohistochemical analysis. Endogenous peroxidase activity was inhibited with hydrogen peroxide, antigen recovery was obtained with citrate buffer at 60°C for 20 min, and nonspecific reactions were blocked with defatted milk and bovine serum albumin during the antibody incubation.
Primary antibodies against tartrate-resistant acid phosphatase (Code SC 30832; Santa Cruz Biotechnology), a biotinylated secondary antibody (Pierce Biotechnology), streptavidin biotin amplifier (Dako, Denmark), and diaminobenzidine (Dako, Denmark) as the chromogen (which gives a brown color to the markings) were used. At the end of the reactions, the slides were counterstained with Harris hematoxylin. The intensity of the immunoreaction was scored as 0-absent, 1-weak, 2-moderate, and 3-intense [26] . To perform the analysis, an optical microscope with a magnification objective of ×160 (Leica Aristoplan Microsystems; Leitz, Benshein, Germany) was used, coupled to an image-capturing camera (Leica DFC 300FX; Leica Microsystems, Heerbrugg, Switzerland) and connected to a Pentium III microcomputer loaded with digitized image analyzer software (Leica Camera Software Box, Leica Imaging Manager, IM50 Demo Software).
Statistical Analysis
Statistical analyses of insulin signaling were performed by using analysis of variance, followed by Tukey's post hoc test when the analysis of variance suggested a significant difference between groups (p < 0.05). The Student's t test was performed for the analysis of K itt values; plasma glucose, insulin, TC, TG, TNF-α, IL-6, osteocalcin, calcium, and fluoride concentrations; and biomechanical properties in the tibia. Statistical analysis of immunohistochemistry was performed by the Mann-Whitney test. The value of p < 0.05 was considered statistically significant. Data analysis was performed with a statistical program (GraphPad Prism version 5.0).
Results
Biochemical Parameters
As shown in Table 1 , the OVX-F group exhibited no changes in plasma glucose concentration, but there was a significant increase (p < 0.05) in plasma insulin concentration. From these values, the HOMA-IR index was calculated, as described in the section BAnalysis Methods.^It was found that the HOMA-IR index was significantly higher (p < 0.05) in the OVX-F group.
The OVX-F group showed a glucose disappearance rate (K itt value) that was significantly lower (p < 0.05) than that of the OVX-C group. Additionally, the OVX-F group showed increased plasma concentrations of calcium, osteocalcin, fluoride, IL-6, TNF-α, TG, and VLDL-C compared with the OVX-C group. However, the treatment with NaF did not cause changes in plasma concentrations of TC, HDL-C, and LDL-C (Table 1) .
Insulin Signaling
In the OVX-C group, there was a significant intra-group difference (p < 0.05) in insulin signaling after insulin stimulation. There was a decrease (p < 0.05) in the pp185 phosphorylation status, after insulin stimulation, in the white adipose tissue of the OVX-F group compared with the OVX-C group (Fig. 1) .
Bone Evaluation of Mineral Density and Microstructure
The value of the total bone area of the tibia was significantly lower (p < 0.05) in the OVX-F group than in the OVX-C group. In addition, the treatment with NaF did not cause changes either in the bone mineral density or in the bone mineral content (Fig. 2a-c) . Figure 3 shows histomorphometric parameters of the OVX-C and OVX-F groups. The OVX-F group showed a significant decrease (p < 0.05) in all parameters analyzed, namely, bone area (B.Ar), trabecular number (Tb.N), and trabecular width (Tb.Wi), compared with the controls. Figure 4 shows the values of (A) stiffness, (B) maximum strength, and (C) tenacity, obtained by 3-point bending flexural tests conducted on the tibia of the animals. Significantly lower values in all three parameters were observed in the OVX-F group. Figure 5 shows that treatment with NaF was able to promote a significant increase in fluoride ion concentration in the tibiae of the OVX-F group compared with the OVX-C group.
Biomechanical Parameters and Assessment of Fluoride Ion Concentration in Bone
Immunohistochemical Analysis
The results obtained from immunohistochemical analysis of the tartrate-resistant acid phosphatase (TRAP) marker are presented in Fig. 6 . There was a more intense immunostaining of TRAP in the OVX-F group compared to the control group (p < 0.05).
Discussion
Chronic treatment with NaF-containing drinking water during 42 days promoted insulin resistance and changes in the insulin signaling and bone biomechanical and histomorphometric properties in OVX rats.
The present study showed that chronic treatment with NaF in OVX rats caused a decrease in the pp185 (IRS-1/IRS-2) tyrosine phosphorylation status in the white adipose tissue, Results are expressed as the mean ± SEM, n = 10. *p < 0.05 compared with the control group OVX-C ovariectomized rats administered an equivalent amount of sodium ions only, OVX-F ovariectomized rats treated with 50 mg/L sodium fluoride, K itt rate constant of glucose disappearance, IL-6 interleukin-6, TNF-α tumor necrosis factor alpha, HOMA-IR homeostasis model assessment of insulin resistance, HDL-C high-density lipoprotein cholesterol, VLDL very low-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol promoting decreased insulin signaling. Previous studies performed in our laboratory, using castrated male rats subjected to a chronic ingestion dosage of NaF (4.0 mg F/kg body weight/day), showed a reduction in the pp185 tyrosine phosphorylation status in muscle and adipose tissue, resulting in decreased insulin signaling in these tissues [12, 13] . These responses suggest that fluoride can cause insulin resistance, because several authors correlated insulin resistance with a decrease in insulin signaling [12, [27] [28] [29] .
The treatment with NaF promoted an increase in the plasma insulin concentration in the OVX-F group, but no difference in blood glucose was observed between the groups. This increase in insulin may be attributed to a response of the animal to the decrease in glucose uptake by the cells due to insulin resistance, making it necessary for the pancreas to increase its production of insulin in order to maintain a normal blood glucose concentration [30] . From the values of glycemia and insulinemia, the HOMA-IR index, which expresses the insulin resistance, was calculated. The value of this index was higher in the OVX-F group than in the OVX-C group, demonstrating that treatment with NaF induced insulin resistance. The results of this study also demonstrated that the rate constant for glucose disappearance (K itt ) in the OVX-F group was reduced relative to that in the controls, reinforcing that the OVX-F group is insulin resistant.
Studies performed in normoglycemic men with insulin resistance have shown that cholesterol synthesis is increased in these patients. Insulin resistance and type 2 diabetes mellitus have been consistently associated with high plasma concentrations of TGs and low plasma concentrations of HDL-C. The increased synthesis of VLDL-C in the liver appears to be the main cause of increased concentrations of TG-rich lipoproteins. This excess of VLDL-C and TG in the liver is associated with elevated plasma levels of fatty acids in patients with insulin resistance [31] . The results of this study showed that treatment with NaF promoted an increase in plasma concentrations of TG and VLDL-C.
Graham et al. [32] showed that rats fed with a hyperlipidic diet developed osteopenia. They investigated in vitro the involvement of T lymphocytes from the bone marrow of these animals and observed an increase of several cytokines, including TNF-α, IL-6, and receptor activator of nuclear factor kappa-B ligand. From these results, they suggested that T lymphocytes play a key role in diet-induced osteoclastogenesis and can contribute to the bone loss associated with osteopenia. The results of the present study showed higher levels of plasma TNF-α and IL-6 in ovariectomized rats treated with NaF. Chiba et al. [11] have shown that administration of NaF to castrated male rats promoted insulin resistance and increased the plasma concentration of TNF-α. The results of this study are thus in agreement with the results of Chiba et al. [11] . Peraldi and Spiegelman [33] suggested that TNF-α may alter the insulin signal transmission by increasing IRS-1 serine phosphorylation. The phosphorylated IRS-1 serine inhibits the tyrosine kinase activity of the insulin receptor, thereby reducing insulin signaling [34] .
In the obesity condition, macrophages produce high levels of TNF-α and IL-6 that promote osteoclast activity, leading to bone resorption [35] . IL-6 is a cytokine that can affect bone mass. The chronic expression of IL-6 increases bone remodeling and causes the loss of bone mass by increasing its reabsorption [36] .
The results of this study showed an increase in plasma calcium levels in the OVX-F group. It is known that osteoporosis in women is associated with a decrease of estrogen, which accelerates bone loss. There are other mechanisms that can lead to hypercalcemia, such as an increase in bone resorption and in intestinal calcium absorption and a decrease in the urinary excretion of calcium [37] . Studies performed with osteoblasts (MC3T3-E1) treated with calcium and fluoride in vitro showed that L-type calcium channels play an important role in this mineral homeostasis, because they affect the osteogenic expression of transcription factors such as activator protein 1, runt-related transcription factor 2, and osterix in These results suggest that the regulation of the expression or activity of the L-type calcium channels can regulate calcium signaling in bone cells and the modulation of these channels can influence bone remodeling in conditions of fluorosis [38] .
Dandona et al. [39] performed a study in healthy men undergoing treatment with sodium fluoride for 3 weeks, and their serum osteocalcin concentrations were measured before, during, and after 3 weeks of the treatment. Results showed increased plasma concentrations of this substance at the end of the treatment. These researchers concluded that fluoride administration in normal individuals during a short period of time increases the serum osteocalcin level. Our results are in agreement with these data, because it was observed that the OVX-F group had higher plasma concentrations of osteocalcin than the control group. Osteocalcin-knockout mice exhibit increased blood glucose and decreased insulin compared with wild-type mice [40] . In this study, it was also found that the insulin secretion and sensitivity to this hormone were reduced in these mice knocked out for osteocalcin. The increased plasma osteocalcin may also have promoted an increase in plasma insulin in the OVX-F group. On the other hand, in our studies, this increase in plasma osteocalcin did not increase insulin sensitivity. In fact, the insulin sensitivity got worse. This response may be because NaF promotes an increased concentration of TNF-α, which in turn promotes insulin resistance [11] . In relation to insulin sensitivity, the effect of this cytokine seems to overcome the effect of osteocalcin in this hormone sensitivity.
Animals in the OVX-F group in this study experienced a decrease in total bone area, but there was no change in the bone mineral content and bone mineral density. There is not always a direct correlation between the occurrence of fractures and the densitometry results. Densitometry measures the calcified bone mass, but not the quality of this bone mass. Some clinical studies have demonstrated that the use of fluoride for the treatment of osteoporosis increases the bone mineral density but does not decrease the risk of vertebral fracture [8, [41] [42] [43] .
A biomechanical study showed a decrease in bone quality in rats treated with fluorine doses of 100 and 150 ppm for 90 days [44] . The results of our present study are in agreement with Søgaard et al. [45] , who also observed a decrease in all the biomechanical parameters in the bones of F-treated OVX rats.
Fernandes et al. [46] performed studies with rats treated with variable doses of NaF administered in drinking water and observed that a dose of 5 ppm fluoride ion did not promote any change in bone formation, whereas the dose of 50 ppm promoted damage in bone formation. The results of TRAP immunostaining corroborate the data of Fernandes et al. [46] that observed an increase in TRAP expression in bone cells treated with 50 ppm of fluoride. The immunostaining of TRAP is an important marker for the characterization of osteoclast activity, and its higher expression can be related to decreased bone area.
The results of this study also showed impairments in the histomorphometric and biomechanical parameters of the bone. A condition of bone fragility was observed, which was verified by the decrease of maximum strength in the tibia of the OVX-F group compared with the control group. In addition, there was a decrease in the bone area, trabecular number, and trabecular width. Grey et al. [4] observed that patients treated with placebo or a low dose of fluoride (2.5, 5, and 10 mg/day) for 1 year did not show significant changes of the skeleton and concluded that therapy with NaF is ineffective for the treatment of osteoporosis.
Shin et al. [47] , in a study performed in men, investigated the association between insulin resistance and bone mineral Original magnification-×160. Scale bars-100 μm density, and it was observed that insulin resistance is a negative predictor of bone health. In addition, the association between insulin level and bone mineral density changed according to the degree of insulin resistance, that is, when the individual is more insulin resistant, the bone mass decreases.
Based on these results, we conclude that treatment with a high dose of NaF did not promote changes in bone mineral density, but it did decrease biomechanical and histomorphometric parameters in the tibia, demonstrating that this treatment promoted the formation of bone of a lower quality. Furthermore, the NaF promoted reductions in insulin signaling and insulin resistance. We emphasize that this hormone resistance worsens with aging. Therefore, the use of NaF for the treatment of osteoporosis should be done cautiously, especially in women post menopause.
